PropertyValue
?:abstract
  • After global health catastrophe due to Coronavirus disease-2019 (COVID-19), a deep impact on the way we perceive our world and our everyday lives has been imprinted Till now, no specific antiviral drug has been proven effective for curing patients Ivermectin, the broad-spectrum macrocyclic lactone has proven to exert antiviral activity against human immunodeficiency virus (HIV), dengue virus and now capability to reduce viral RNA up to 5,000-fold after 48 h of infection with SARS-CoV-2 [ABSTRACT FROM AUTHOR] Copyright of Biomedica is the property of Knowledge Bylanes and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder\'s express written permission However, users may print, download, or email articles for individual use This abstract may be abridged No warranty is given about the accuracy of the copy Users should refer to the original published version of the material for the full abstract (Copyright applies to all Abstracts )
is ?:annotates of
?:creator
?:journal
  • Biomedica
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Ivermectin: An Anti-Parasitic Drug that has Potential for Repurposing for COVID-19
?:type
?:who_covidence_id
  • #830365
?:year
  • 2020

Metadata

Anon_0  
expand all